Literature DB >> 22947894

Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani.

Magdalena Nascimento Rennó1, Tanos Celmar Costa França, Dirlei Nico, Clarisa B Palatnik-de-Sousa, Luzineide Wanderley Tinoco, José Daniel Figueroa-Villar.   

Abstract

In this study the recombinant enzyme nucleoside hydrolase of Leishmania donovani (rLdNH) was expressed in Escherichia coli in connection with maltose binding protein (MBP). The rLdNH-MBP showed efficient a significant in vitro activity with inosine as substrate. From the coupled reaction with xanthine oxidase (XO) it was possible to determine the kinetic constants of rLdNH-MBP as K(M) (434 ± 109 μM) and V(max) (0.20 ± 0.02 μM). In addition, two nucleoside analogs (compounds 1 and 2) were tested as prototypes of rLdNH inhibitors. These compounds presented high affinity for the enzyme with K(i) values of 1.6 ± 0.2 and 17.0 ± 2.1 μM, respectively, as well as 271 and 26 folds higher than the affinity constant found for inosine. We also determined the type of enzyme inhibition, using double-reciprocal plot for these two compounds and the results confirmed a competitive inhibition. Additional docking studies showed the binding manner of compounds 1 and 2 inside the active site of LdNH revealing the essential residues for an effective inhibition. These results confirm that compounds 1 and 2 are strong rLdNH-MBP inhibitors.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22947894     DOI: 10.1016/j.ejmech.2012.07.052

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Structural explanation for the tunable substrate specificity of an E. coli nucleoside hydrolase: insights from molecular dynamics simulations.

Authors:  Stefan A P Lenz; Stacey D Wetmore
Journal:  J Comput Aided Mol Des       Date:  2018-11-26       Impact factor: 3.686

2.  New Leishmania donovani nucleoside hydrolase inhibitors from Brazilian flora.

Authors:  Charlotte Nirma; Gregorio Torres Rangel; Marina Amaral Alves; Livia Marques Casanova; Mayara Monteiro Moreira; Luanna Monteiro Rodrigues; Lidilhone Hamerski; Luzineide Wanderley Tinoco
Journal:  RSC Adv       Date:  2019-06-13       Impact factor: 4.036

Review 3.  The Delay in the Licensing of Protozoal Vaccines: A Comparative History.

Authors:  Clarisa Beatriz Palatnik-de-Sousa; Dirlei Nico
Journal:  Front Immunol       Date:  2020-03-06       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.